Unique Success-Driven FTE for Drug Discovery

View in browser

Follow us on Linkedin to receive more updates!

Enjoy the FTE flexibility without losing sight of accountability

Together, we can make drug discovery more sustainable!

Multispan has played a pivotal role in advancing

numerous drugs into the clinic for two decades!

• Innovative cost structure:

Flexibility + Guaranteed pre-defined success @ each step

• Free access to jump-start and be more efficient:

>2000+ pre-validated GPCR HTS assays developed in-house

>600+ MULTISCREEN™ stable cell line clones

>100 years of deep expertise in cell assays

• Drive in-vitro pharmacology from target to IND

HANDS-FREE!

Maximize the success of EACH project through leveraging technology and making EVERY cell line, assay, and plate count using MULTISCREEN™ HTS in-vitro pharmacology platform

multispaninc.comwp-contentuploadsFunnel-image-v5-795x1024

• Weekly SAR primary assays: 1 day!

• Monthly SAR secondary assays: 5 days

• HTS of 180K compound library: 2-months

• 32-GPCR off-target functional assay panel: 2 weeks

Explore More!

What do our customers say?

"We performed small molecule activity screening for GPCR targets with Multispan over the span of the past 3 years. Multispan team has been very responsive with study requests and took initiatives to help with trouble shooting. The team performed studies with rapid turnaround time and reproducible results. With the Multispan team’s help, we were able to advance our discovery efforts into DC selection in less than 9 months. We look forward to the team’s continuous expansion of their portfolio and hopefully someday we can work on another discovery projects together."

---Fei Liu, Ph.D

Principal Scientist, Project manager, Oppilan Pharma

info@multispaninc.com

www.multispaninc.com